Author:
Wu Jianwei,Li Hui,Lin Yuning,Chen Ziqian,Zhong Qun,Gao Hong,Fu Liyuan,Sandrasegaran Kumar
Publisher
Springer Science and Business Media LLC
Subject
Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,General Medicine,Radiological and Ultrasound Technology
Reference30 articles.
1. Hamm B, Staks T, Muhler A, et al. (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195(3):785–792
2. Kim H, Kim MJ (2013) Hepatic uptake of gadoxetic acid. Radiology 267(1):314–315
3. van Montfoort JE, Stieger B, Meijer DK, et al. (1999) Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 290(1):153–157
4. Jang YJ, Cho SH, Bae JH, et al. (2013) Noninvasive assessment of hepatic fibrosis using gadoxetate-disodium-enhanced 3T MRI. Ann Hepatol 12(6):926–934
5. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, et al. (1992) Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183(1):59–64
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献